Ohcanbohtosat - Axel Paehler

  • Čájehuvvo 1 - 2 / 2
Aiddostahte ozu
  1. 1
    Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein

    Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein Dahkki Holger Fischer, Mohammed Ullah, Cecile C. de la Cruz, Thomas Hunsaker, Claudia Senn, Thomas Wirz, Björn Wagner, Dragomir Draganov, Faye Vazvaei, Massimiliano Donzelli, Axel Paehler, Mark Merchant, Li Yu

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression

    Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression Dahkki Lothar Lindemann, Richard H. Porter, Sebastian H. Scharf, Basil Kuennecke, Andreas Bruns, Markus von Kienlin, Anthony Harrison, Axel Paehler, Christoph Funk, Andreas Gloge, Manfred Schneider, Neil Parrott, Liudmila Polonchuk, U Niederhäuser, Stephen R. Morairty, Thomas S. Kilduff, Eric Vieira, Sabine Kolczewski, Juergen Wichmann, Thomas Härtung, Michael Honer, Edilio Borroni, Jean‐Luc Moreau, Eric Prinssen, Will Spooren, Joseph G. Wettstein, Georg Jaeschke

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: